Children Vaccinated With Messenger RNA COVID-19 Have Higher Risk of Certain Illnesses

Children Vaccinated With Messenger RNA COVID-19 Have Higher Risk of Certain Illnesses

It has been reported that children vaccinated with messenger RNA Covid-19 show higher risks of some illness, according to a recent study. Check out the new reports below.

Vaccinated children at higher risk for disease

A recent study found that children who participated in clinical trials of Moderna or Pfizer COVID-19 vaccines were at a higher risk of certain illnesses.

According to Dr. Christine Stabell Benn and other researchers, children who received one of the mRNA vaccines were more susceptible to respiratory tract infections and serious side effects compared to those who received a placebo.

The study focused on examining whether the vaccines could have any unintended effects beyond COVID-19.

The researchers analyzed data from six studies, covering a total of 25,549 people, out of which around 68 percent received the vaccine and the rest received a placebo.

The data was sourced from regulatory websites and other credible sources.

Moderna and Pfizer conducted clinical trials with children of different age groups.

Moderna enrolled children from 6 months to 11 years of age, while Pfizer’s trial included children aged 5 months to 11 years. The researchers analyzed the results for all children, and also separately for younger, young, and oldest age groups.

The study found that the risk of severe adverse events, such as events leading to death or hospitalization, was higher for the younger and oldest recipients, but not for the youngest children.

In addition, the 12- to 17-year-olds faced an increased risk of severe adverse events, which were medically significant but not immediately life-threatening.

However, this higher risk was not statistically significant in the younger age group, and the risk was lower in the youngest group.

Although the vaccine showed promising results in preventing influenza in children, the study found that younger children were at a higher risk of developing respiratory tract infections such as bronchitis and respiratory syncytial virus.

It’s important to note that these types of infections were not included in the vaccine trials for younger and older children. Additionally, the research also revealed that vaccinated children faced a higher risk of skin and tissue disorders.

Rada Mateescu

Passionate about freedom, truth, humanity, and subjects from the science and health-related areas, Rada has been blogging for about ten years, and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.